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Prevalence and risk factors associated with perianal 
ulcer in advanced acquired immunodeficiency syndrome 
Maria Claudia Nascimento,(‘) Cl&rdio Sergio Pannuti, c2) Cristiane Murta Ramalho Nascimento,c3) 
Laura Masami Sumitac2) and Jose Eluf-Netoc3) 
Background: The aims of this study were to evaluate the prevalence of perianal ulcer in AIDS patients with advanced 
disease, and to investigate risk factors associated with these lesions. 
Methods: A cross-sectional study was conducted to determine the prevalence and risk factors associated with the 
presence of perianal ulcer in AIDS patients. A type-specific polymerase chain reaction (PCR) assay was carried out 
for detection of herpes simplex virus (HSV) DNA on swabs obtained from the ulcerative lesions. 
Results: In total, 272 hospitalized AIDS patients were included in the study, for evaluation of the risk factors 
associated with the lesion. Perianal ulceration was found in 25 of 272 patients (prevalence=9.2%). The presence of 
HSV DNA was shown by type-specific PCR in 22 of 23 (95.6%) patients. Multivariate analysis revealed that a history 
of esophageal candidiasis (odds ratio (OR)=15.1; 95% confidence interval (CI)=3.8-59.1) and a history of perianal 
ulcer (OR= 19.2; 95 % CI 6.4-58.1) were significant risk factors for the presence of perianal ulcer. 
Conclusion: We conclude that a history of perianal ulcer and a history of esophageal candidiasis were risk factors 
independently associated with perianal ulcer in AIDS patients with advanced disease. 
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INTRODUCTION 
Ulcerated perianal lesions are commonly observed in 
patients with AIDS. In advanced stages of disease, pre- 
valence rates as high as lo-14% have been reported.iA 
Unless a specific treatment is implemented, these lesions 
may continue to enlarge peripherally, causing pain and 
discomfort, and may increase in size up to 100 cm2.5-8 
Mucocutaneous ulcers caused by herpes simplex 
virus (HSV) are usually diagnosed by viral culture from 
a swab sample obtained from the lesion.9.1n The poly- 
merase chain reaction (PCR) has been used to detect 
genital ulcers and also asymptomatic anogenital shed- 
ding of HSV.“.‘* PCR was recently shown to be useful 
in detecting HSV DNA in perianal ulcers of AIDS 
patients.4 However, although HSV seems to be the main 
etiologic agent, cytomegalovirus, Treponema pallidurn 
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and other agents have also been associated with perianal 
ulceration.‘,‘3-i” 
While perianal ulceration is a common cause of 
morbidity in AIDS patients, data on risk factors for this 
condition are scarce. The aim of this study was to deter- 
mine the prevalence and risk factors for perianal ulcer 
in patients with advanced AIDS. 
PATIENTS AND METHODS 
Setting 
The Instituto de Infectologia Emflio Ribas (IIER), SBo 
Paulo City, Brazil, is a 250-bed, tertiary-care, state hospital 
for infectious diseases. In recent years, half of its beds 
have been occupied by AIDS patients. 
Patients and study design 
A cross-sectional study was conducted to estimate the 
prevalence and to evaluate risk factors that might pre- 
dict perianal ulcer in AIDS patients. Over an 8-month 
period (October 1996 to June 1997) all class C AIDS 
patients (classified according to modified CDC criteria),l’ 
aged at least 18 years old, who were consecutively 
admitted to the IIER, were examined for the presence 
of perianal ulcer. Each patient was seen within 72 h of 
admission. If a patient was hospitalized more than once, 
only the first hospitalization was considered, 
The patients were given a standardized, structured 
questionnaire. One hundred and forty-five patients who 
could not answer the questionnaire because of cognitive 
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disorders or a severe clinical condition were considered 
ineligible. Twenty-nine other cases had been hospital- 
ized for the investigation of signs or symptoms associa- 
ted with HIV infection, but could not be classified as 
AIDS cases and were not included in the study. 
Before being interviewed, 38 patients died, 30 
were discharged from the hospital, and 16 had been 
hospitalized twice. Thus, in total, 288 patients were 
eligible for the study. Of these, 16 refused to participate, 
and 272 were included. All investigations were per- 
formed after informed consent was obtained. This study 
was approved by the Committee of Ethical Research of 
the IIER. 
Data and specimen collection 
The patients were interviewed privately in the hospital 
by one of the authors, using a questionnaire that 
addressed indicators of socioeconomic status (per capita 
income and educational level) and sexual activity. 
Variables related to previous or present opportunistic 
diseases and risk behavior for HIV infection were also 
investigated. The per capita income was obtained by 
dividing the number of minimum wages received per 
residence by the number of subjects living in the same 
dwelling. Educational level was classified as none, ele- 
mentary (complete or incomplete), secondary (complete 
or incomplete), and college (university, complete or in- 
complete). 
Receptive anal intercourse, history of genital ulcer 
and history of perianal ulcer were investigated through 
personal history and hospital records. 
The occurrence of opportunistic infectious diseases 
was investigated by consulting hospital records and the 
physician assigned to each patient. 
The perianal region of all study participants was 
examined by the same investigator. Perianal ulcer was 
defined by the presence of an ulcerative lesion detected 
by medical examination. When a perianal ulcer was 
detected, a pre-moistened cotton-tipped swab was rubbed 
over the perianal ulcer, and the specimen was placed in 
3 mL of Hanks balanced salt solution containing anti- 
biotics (vancomycin and amphotericin B). Samples were 
taken to the laboratory within 2 h of collection. 
Detection of HSV DNA by PCR 
A type-specific, PCR-based assay was used for detection 
and direct typing, as described previously.4 This assay 
exploits differences between the DNA sequences of the 
DNA polymerase genes of HSV-1 and HSV-2. 
Statistical analysis 
To estimate the association between perianal ulcer 
and the variables of interest, odds ratios (OR) and 95% 
confidence intervals (CI) were calculated using uncon- 
ditional logistic regression. ls Statistical significance was 
evaluated by the likelihood ratio (LR) test. For 
factors susceptible to ranking, a test for linear trend 
was used. 
Logistic regression was used to construct a model to 
control for the potential confounding effects of other 
variables. Age and the factors found to be significantly 
related to perianal ulcer in univariate analysis were 
included in the final model. Variables with more than 
20% missing values were not included in the final model. 
RESULTS 
Perianal ulcer was found in 25 of the 272 patients 
studied (prevalence=9.2%; 95% CI 6.0-13.3%). 
A perianal swab was obtained from 23 of the 25 
subjects with perianal ulcer. Of the two patients from 
whom a perianal swab was not obtained, one did not 
allow specimen collection, and the other had used 
acyclovir for more than 1 month to treat a recurrent 
lesion. Overall, HSV DNA was detected in 22 of 23 
(95.7%) cases by PCR. This type-specific assay detected 
HSV type 2 in all samples. 
No differences were observed in the demographic 
characteristics of AIDS patients with and without peri- 
anal ulcer (Table 1). 
Regarding risk behavior for HIV infection, men 
reporting male-male sex showed the highest risk of 
perianal ulcer (OR=4.1; 95% CI 1.3-12.8) (Table 2). 
Seventy-five patients (27.6%) reported drug addiction, 
and five (1.8%) reported HIV infection through blood 
transfusion. None of these variables was associated with 
perianal ulcer. The lesion was more frequent among 
patients reporting receptive anal intercourse (OR=3.0; 
95% CI 1.3-7.0). A history of genital ulcer was reported 
by 13.2% of patients with perianal ulcer (OR=1.8; 95% 
CI 0.7-4.5). Among the variables related to sexual 
behavior, history of perianal ulcer was the strongest 
predictor for perianal ulcer (OR=9.9; 95% CI 4.1-24.1) 
(Table 2). 
Overall, pulmonary tuberculosis was the most pre- 
valent opportunistic infection among the 272 AIDS 
patients studied, being observed in 128 of 270 (47.4%) 
subjects. However, esophageal candidiasis was the only 
opportunistic infection significantly associated with peri- 
anal ulcer (OR=6.7; 95% CI 2.2-20.2) (Table 3). 
The effect of antiretroviral agents was considered 
only for those patients undergoing treatment for 2 
months prior to entering the study. In total, 141 (54.2%) 
patients were receiving highly active antiretroviral 
therapy (HAART); the prevalence of perianal ulcer 
(9.9%) was similar to that found among patients not 
receiving this therapy (9.2%) (Table 4). 
The CD4+ cell counts considered were those 
obtained within 3 months of the interview. The median 
CD4+ cell count of the patients in the present study was 
25 cells/mm3. The association between the prevalence 
of perianal ulcer and CD4+ cell counts was nearly signi- 
ficant (P=O.O54) (Table 4). 
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Table 1. Prevalence of perianal ulcer in AIDS patients according to sociodemographic characteristics and associated odds ratios (OR) 
Perianal ulcer 
Characteristics Total No. % OR 95% Cl 
Age (years) 
<30= 
31-40 
>40 
LR (I df)=0.70; P=O.40 
Sex 
Femalea 
Male 
LR (1 df)=0.03; P=O.87 
Family per capita income 
(minimal wages)b 
50.5a 
0.6-3.0 
>3.0 
LR (I df)=2.6; P=O.ll 
Educational levelc 
Nonea 
Primary 
Secondary 
College 
LR (1 df)=0.97; P=O.33 
91 8 8.8 1.0 
122 9 7.4 0.8 
59 8 13.6 1.6 
0.3-2.2 
0.6-4.6 
69 6 8.7 1.0 
203 19 9.4 1.1 0.4-2.8 
47 2 4.3 1.0 - 
88 8 9.1 2.3 0.5-11.1 
64 8 12.5 3.2 0.7-I 5.9 
19 1 5.3 1.0 
162 14 8.6 1.7 
60 6 10.0 2.0 
30 4 13.3 2.8 
0.2-I 3.7 
0.2-I 7.8 
0.3-26.9 
aReference group. “Data not available for 73 patients. CData not available for one patient. 
Univariate analysis showed that the factors associ- of these factors, except male-male sex (not applicable to 
ated with perianal ulcer were: male-male sex (OR =4.1; female patients), were included in the final model (Table 
95% CI 1.3-12.8), history of perianal ulcer (OR=9.9; 5). The variables shown to be risk factors for perianal 
95% CI 4.1-24.1), history of esophageal candidiasis ulcer at a statistically significant level were history of 
(OR=6.7; 95% CI 2.2-20.2), and history of receptive esophageal candidiasis (OR=15.1; 95% CI 3.8-59.1) and 
anal intercourse (OR=3.0;95% CI 1.3-7.0).Age and all history of perianal ulcer (OR=19.2; 95% CI 6.4-58.1). 
Table 2. Prevalence of perianal ulcer in AIDS patients according to some risk factors for HIV infection and some sexual activity 
indicators, and associated odds ratios (OR) 
Perianal ulcer 
Characteristics Total No. % OR 95% Cl 
Male-male sex 
Noa 
Yes 
LR (1 df)=7.1; P=O.Ol 
Lifetime number of sexual partnersb 
<5” 
6-10 
>I0 
LR (I df)=O.Ol; P=O.94 
History of perianal ulcer< 
Noa 
Yes 
LR (1 df)=23.88; P<O.OOl 
History of genital ulcerd 
Noa 
Yes 
LR (1 df)=1.80; P=O.l8 
Receptive anal intercoursee 
Never” 
Ever 
LR (1 df)=7.54; P=O.O2 
100 4 4.0 1.0 
103 15 14.6 4.1 1.3-I 2.8 
58 4 6.9 1.0 
40 5 12.5 1.9 0.5-7.7 
98 7 7.1 1.0 0.3-3.7 
231 12 5.2 1.0 
37 13 35.1 9.9 4.1-24.1 
191 15 7.9 1.0 
76 10 13.2 1.8 0.7-4.5 
152 9 5.9 
102 16 15.7 
1.0 - 
3.0 1.3-7.0 
aReference group. bData not available for 76 patients. (Data not available for 4 patients. dData not available for 5 patients. eData not available for 18 
patients. 
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Table 3. Prevalence of perianal ulcer in AIDS patients according to opportunistic diseases and associated odds ratios (OR) 
Perianal ulcer 
Opportunistic disease Total No. % OR 95% a 
Pulmonary tuberculosisa 
Nob 
Yes 
LR (1 df)=0.23; P=O.63 
Extrapulmonary tuberculosisa 
Nob 
Yes 
LR (1 df)=0.26; P=O.61 
Mycobacteriosisa 
Nob 
Yes 
LR (1 df)=3.30; P=O.O7 
CNS cryptococcosisa 
Nob 
Yes 
LR (1 df)=1.78; P=O.18 
Esophageal candidiasisa 
Nob 
Yes 
LR (1 df)=9.60; P=O.O02 
CNS toxoplasmosisa 
Nob 
Yes 
LR (1 df)=0.16; P=O.69 
Pulmonary pneumocystosisa 
Nob 
Yes 
LR (1 df)=O.lO; P=O.75 
Cytomegalovirus diseasea 
Nob 
Yes 
LR (1 df)=0.04; P=O.84 
Kaposi’s sarcomaa 
Nob 
Yes 
LR (1 df)=1.72; P=O.19 
142 12 8.5 1.0 
128 13 10.2 1.2 0.5-2.8 
226 20 8.9 1.0 
44 5 11.4 1.3 0.5-3.7 
253 21 8.3 1.0 
17 4 23.5 3.4 1.0-11.4 
240 24 10.0 1.0 - 
30 1 3.3 0.3 0.04-2.4 
253 19 7.5 1.0 - 
17 6 35.3 6.7 2.2-20.2 
193 17 8.8 1.0 
77 8 10.4 1.2 0.5-2.9 
187 18 9.6 1.0 
83 7 8.4 0.9 0.3-2.2 
234 22 9.4 1.0 
36 3 8.3 0.9 0.2-3.1 
255 22 8.6 1.0 - 
15 3 20.0 2.6 0.7-10.1 
aData not available for two patients. 
bReference group. 
CNS, central nervous system. 
Table 4. Prevalence of perianal ulcer in AIDS patients accordinq to CD4+ cell count and use of HAART and associated odds ratios (OR) 
Perianal ulcer 
Characteristics Total No. % OR 95% Cl 
CD4+ cell counta 
54 50b 
51-200 
>200 
LR (1 df)=3.72; P=O.O54 
125 19 15.2 1.0 
60 4 6.7 0.4 0.1-0.2 
32 2 6.3 0.4 0.1-I .7 
HAART= 
Nob 
Yes 
LR (1 df)=0.04; P=O.85 
119 11 9.2 1.0 
141 14 9.9 1.1 0.5-2.5 
aData not available for 55 patients. 
bReference group. 
CData not available for 12 patients. 
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Table 5. Crude and adjusted odds ratios (OR) of perhal her 
in AIDS patients associated with selected factors 
Characteristics Crude OR ORa 95% Cl 
Age (years) 
530 
31-40 
>40 
LR (1 df)=3.19; P=O.O7 
1.0 1.0 
0.8 0.7 0.2-2.4 
1.6 3.8 1.0-I 3.4 
Esophageal candidiasis 
No 
Yes 
LR (1 df)=13.9; P<O.OOl 
1.0 1.0 
6.7 15.1 3.8-59.1 
History of perianal ulcer 
No 
Yes 
LR (1 df)=24.4; P<O.OOl 
1.0 1.0 
9.9 19.2 6.4-58.1 
Receptive anal intercourse 
No 
Yes 
LR (1 df)=1.4; P=O.2 
1.0 1.0 
3.0 1.8 0.7-5.0 
aOdds ratios adjusted for all the factors included in the table. 
DISCUSSION 
In the present study, the prevalence of perianal ulcer 
was 9.2% among 272 AIDS patients hospitalized for 
treatment of opportunistic infections. In most (95.5%), 
HSV DNA was detected in the lesion by PCR. 
In a previous study, HSV DNA could be demon- 
strated in 36 of 41 (87.8%) perianal ulcers of AIDS 
patients using the same PCR assay,4 and all of the five 
PCR-negative patients had other etiologies for the ulcer. 
In the present study, HSV DNA was not detected in only 
a single case (l/23); however, the ulcer healed 2 weeks 
after treatment with oral acyclovir. This finding high- 
lights the role of HSV as the most important etiologic 
agent in perianal ulcers in patients with advanced 
AIDS. 
The prevalence of HSV ulcerative lesions increases 
in AIDS patients with advanced immunodepression 
(measured by CD4’ cell counts).19 In the present study, 
the median CD4’ cell count was lower in AIDS patients 
with perianal ulcer (25 cells/mm3) than in patients with- 
out the lesion (76 cells/mm”). However, only a marginal 
association was found between the presence of perianal 
ulcer and CD4+ cell counts (P=O.O54). All patients in 
the present study were hospitalized for the treatment 
or investigation of an opportunistic disease, and the 
majority had ~50 CD4’ cells/mm” (median 25 cells/ 
mm3). This fact may have led to homogeneity in CD4+ 
cell counts within the group, and may be the underlying 
reason for the lack of association between perianal ulcer 
and CD4+ cell count in this study. 
A substantial decrease in the incidence of Kaposi’s 
sarcoma, non-Hodgkin’s lymphoma and opportunistic 
infections has been observed after the introduction of 
HAART.*‘&*’ In an era of widespread use of HAART, 
the fact that 119 (45.8%) patients were not receiving a 
potent combination of antiretroviral therapy may have 
led to an overestimation of the prevalence of perianal 
ulcer. Otherwise, the prevalence of perianal ulcer in the 
present series might have been even higher had patients 
who died or who could not be assessed because of 
cognitive disorders or severe clinical conditions been 
included in the present study. 
The sociodemographic characteristics were not 
associated with the presence of ulcerative perianal 
lesions in this study. 
Overall, the most prevalent opportunistic infection 
diagnosed in the present study was pulmonary tuber- 
culosis, observed in 47.4% of patients. This finding was 
expected, considering the high prevalence of tuberculosis 
in Brazil, and that this incidence is higher when CD4’ 
cell counts are less than 200 cells/mm3.24~2s 
The only opportunistic disease that was an inde- 
pendent risk factor for perianal ulcer in AIDS patients 
was esophageal candidiasis (OR=15.1; 95% CI 3.8- 
59.1). Since there is no pathogenic relationship between 
these two entities, a possible explanation is that both 
esophageal candidiasis and herpetic perianal ulcer occur 
more frequently in highly immunocompromised patients. 
The low median CD4’ cell counts of the patients in the 
present study (25 cells/mm’) support this idea. 
Based on controlled studies,26,27 the 1999 US Public 
Health Service and Infectious Diseases Society of 
America guidelines for the prevention of opportunistic 
infections in persons infected with immunodeficiency 
virus recommend daily suppressive therapy when HSV 
recurrences are frequent or severe.28 In the present study, 
the strong association between history of perianal ulcer 
and a subsequent lesion (OR=19.2; 95% CI 6.4-58.1) 
provides additional support for this recommendation. 
Receptive anal intercourse was associated with peri- 
anal ulcer in the univariate analysis (P=O.O2), but was 
not statistically significant when tested in the multi- 
variate analysis. However, underestimation of the 
number of subjects declaring this practice may have 
led to some degree of misclassification. The variable 
male-male sex was also associated with the lesion in the 
univariate analysis (OR=4.1; 95% CI 1.3-12.8), but was 
not statistically significant in the regression model. 
We conclude that the prevalence of perianal ulcer 
in AIDS patients hospitalized for treatment of other 
opportunistic infections is high, and that HSV-2 is respon- 
sible. A history of perianal ulcer and a history of eso- 
phageal candidiasis are strong risk factors independently 
associated with perianal ulcer in AIDS patients. 
Controlled studies would be useful to establish the 
benefit of prophylaxis with acyclovir in this particular 
subset of AIDS patients. 
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